A cross-reactive pH-dependent anti-EGFR antibody obtained by structure-guided engineering exhibits tumor selectivity and improved tumor penetration
Molecular Therapy - Oncolytics(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Molecular Therapy - Oncolytics(2022)